Diagnostik und Therapie des hepatozellulären Karzinoms

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Due to the increase in steatotic liver diseases, the incidence is currently rising, particularly in Western countries. Depending on the patient’s performance status, liver function and tumor stage, a wide range of therapeutic options are now available. These range from surgical procedures, such as liver transplantation and resection, to interventional therapies, such as ablation or transarterial chemoembolization, to systemic therapies in advanced stages. The recent approval of immunotherapies has significantly improved the landscape of systemic treatment options. Due to the diversity of therapeutic approaches, multidisciplinary care in experienced centers with a focus on liver tumors is crucial.